Interpretation:
The phenotype of the immature B cells (hematogones) is essentially normal except absence of CD20, which is most likely related to Rituximab treatment. No evidence of leukemia.
The phenotype of the immature B cells (hematogones) is essentially normal except absence of CD20, which is most likely related to Rituximab treatment. No evidence of leukemia.